A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia
Author:
Affiliation:
1. Vascular Surgery Department of Xuan Wu Hospital, Institute of Vascular Surgery; Capital Medical University; Beijing; China
2. Beijing Northland Biotech. Co., Ltd; China
3. ViroMed Co., Ltd; Seoul; Republic of Korea
Publisher
Wiley
Subject
Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Reference31 articles.
1. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000;Selvin;Circulation,2004
2. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;J Vasc Surg,2007
3. Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting;Hirsch;Circulation,2006
4. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia;Schanzer;J Vasc Surg,2008
5. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases;Aoki;J Atheroscler Thromb,2000
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04
2. Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysis;European Journal of Vascular and Endovascular Surgery;2024-07
3. Complementary Gene Therapy after Revascularization with the Saphenous Vein in Diabetic Foot Syndrome;Genes;2023-10-20
4. Gene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo‐controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of human hepatocyte growth factor;International Wound Journal;2023-05-25
5. Charcot–Marie–Toothneuropathies: Current gene therapy advances and the route toward translation;Journal of the Peripheral Nervous System;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3